Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 6/20 | 0.33 |
| ▸ | HCRTR2 | O43614 | 5/20 | 0.33 |
| ▸ | BTK | Q06187 | 4/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15273580 | 1.00 | CYP3A4 (0.39) | CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6 | |
| SCHEMBL9914929 | 0.96 | CYP3A4 (0.40) | CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6 | |
| SCHEMBL9914932 | 0.94 | CYP3A4 (0.39) | CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6 | |
| SCHEMBL15273565 | 0.92 | CYP3A4 (0.39) | CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6 | |
| SCHEMBL15273622 | 0.92 | CYP3A4 (0.39) | CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6 | |
| SCHEMBL9914942 | 0.91 | CYP3A4 (0.38) | CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6 | |
| SCHEMBL9914912 | 0.91 | CYP3A4 (0.38) | CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6 | |
| SCHEMBL9914971 | 0.91 | CYP3A4 (0.38) | CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6 | |
| SCHEMBL9914907 | 0.90 | CYP3A4 (0.37) | CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6 | |
| SCHEMBL9914941 | 0.90 | CYP3A4 (0.37) | CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2646439-B1 | ALKYL AMIDES AS HIV ATTACHMENT INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2016-05-25 | — | — | EP | disclosed |
| US-8912195-B2 | Alkyl amides as HIV attachment inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-12-16 | — | — | US | disclosed |
| US-8912195-B2 | Alkyl amides as HIV attachment inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-12-16 | — | — | US | disclosed |
| US-20130252968-A1 | ALKYL AMIDES AS HIV ATTACHMENT INHIBITORS | VIIV HEALTHCARE UK (NO. 5) LIMITED (GB) | 2013-09-26 | — | — | US | disclosed |
| US-20130252968-A1 | ALKYL AMIDES AS HIV ATTACHMENT INHIBITORS | VIIV HEALTHCARE UK (NO. 5) LIMITED (GB) | 2013-09-26 | — | — | US | disclosed |
| WO-2012075235-A1 | ALKYL AMIDES AS HIV ATTACHMENT INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130252968-A1 | ALKYL AMIDES AS HIV ATTACHMENT INHIBITORS | NAPA, ASNS, CD4 | CYP3A4 164/4885CYP2C9 500/4885CYP1A2 358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.